Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite

Enrico Compalati; Antonio Rinciani

首页> 外文期刊>World Allergy Organization Journal >Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite

【24h】

Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite

机译：小儿房尘螨过敏性鼻炎伴/不伴哮喘的小儿过敏性鼻炎单体注射免疫疗法的安全性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Allergy Organization Journal》 |2015年第1期|共页
作者
Enrico Compalati; Antonio Rinciani;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类变态反应性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms [J] . Mosbech Holger, Canonica G. Walter, Backer Vibeke, Annals of allergy, asthma, and immunology . 2015,第2期

机译：SQ屋尘螨舌下施用免疫治疗片（ALK）可改善患有屋尘螨过敏性哮喘和鼻炎症状的患者的过敏性鼻炎
2. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma [J] . Allergy . 2020,第8期

机译：房屋粉尘诱导过敏性鼻炎和哮喘患者皮下全牙科治疗的真实迹象
3. Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial [J] . Takao Fujisawa, Terufumi Shimoda, Keisuke Masuyama, Allergology international: official journal of the Japanese Society of Allergology . 2018,第3期

机译：日本屋尘螨诱发的过敏性鼻炎和过敏性支气管哮喘患者使用TO-204皮下免疫疗法的长期安全性：多中心，开放标签临床试验
4. Sublingual immunotherapy in children with house dust mite induced allergic asthma [C] . Kumar Suman, Pey N., Sharma Nirankar, International Primary Care Respiratory Group . 2010

机译：含有房屋粉尘诱发过敏性哮喘的儿童的舌下免疫疗法
5. Structural, Functional and Immunological Studies of Group 1 and 2 House Dust Mite and Profilin Allergens for the Development of Allergen Specific Diagnostics and Immunotherapy [D] . Kapingidza, Anyway B. 2020

机译：第1族和2次房屋粉尘和毛细血管过敏原特异性诊断和免疫疗法的结构，功能和免疫学研究
6. Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite [O] . Enrico Compalati, Antonio Rinciani 2015

机译：小儿房尘螨过敏性鼻炎伴/不伴哮喘的小儿过敏性鼻炎单体注射免疫疗法的安全性
7. Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite [O] . 2015

机译：小儿房尘螨过敏性鼻炎伴/不伴哮喘的小儿过敏性鼻炎的单次注射免疫疗法的安全性

Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite

著录项

相似文献

相关主题

期刊订阅